Get an Ozempic® prescription online in Canada — fast & secure

In Canada, only licensed healthcare providers regulated by provincial or territorial authorities can prescribe Ozempic®. This typically includes:

• Family physicians (MDs)
• Nurse practitioners (NPs) with prescribing authority
• Other licensed clinicians authorized under provincial regulations
• Licensed doctors through telehealth platforms like Your Doctors Online

Ozempic dosing typically starts at 0.25 mg once weekly for 4 weeks, then increases to 0.5 mg once weekly. If additional control is needed, a clinician may increase further (for example, to 1 mg, and in some cases higher) based on response and tolerability. Dose changes should be clinician-directed.

Ozempic® is approved for Type 2 diabetes to help manage blood sugar levels and reduce the risk of major cardiovascular events. While weight loss is a common side effect, it is not officially approved for weight loss, and prescribing it for that purpose is considered “off-label” use. Wegovy® is a Health Canada-approved weight-loss brand containing Semaglutide. It uses a higher maximum dose (2.4 mg) than Ozempic (2 mg maximum dose) and is specifically indicated for chronic weight management in adults (and some adolescents) with obesity or those who are overweight with at least one weight-related condition. The “better” choice depends on your BMI, medical history, side effect risk, and insurance rules. Read more on Wegovy vs Ozempic for weight loss. Only a licensed healthcare provider can guide the decision.

Ozempic® cost varies by retailer pricing, dosage, and insurance plans. Many telehealth programs charge a separate membership/visit fee, while the medication itself is typically paid to the pharmacy. Please note that the consultation fee is separate from the medication cost.

If Ozempic® isn’t the right medication, providers may discuss other online GLP-1 and weight-management options based on your health profile, goals, and side effect tolerance. Many programs position GLP-1 care as a treatment plan with ongoing care, not a one-time script. Providers may prescribe GLP-1 medications or other weight-management treatments when appropriate.

These include:

• Mounjaro
• Rybelsus
• Wegovy
• Victoza
• Dulaglutide
• Liraglutide

Ozempic® is approved for Type 2 diabetes to help manage blood sugar levels and reduce the risk of major cardiovascular events. While weight loss is a common side effect, it is not officially approved for weight loss, and prescribing it for that purpose is considered “off-label” use. Wegovy® is a Health Canada-approved weight-loss brand containing Semaglutide. It uses a higher maximum dose (2.4 mg) than Ozempic (2 mg maximum dose) and is specifically indicated for chronic weight management in adults (and some adolescents) with obesity or those who are overweight with at least one weight-related condition. The “better” choice depends on your BMI, medical history, side effect risk, and insurance rules. Read more on Wegovy vs Ozempic for weight loss. Only a licensed healthcare provider can guide the decision.

Ozempic® is a once-weekly injection under the skin, taken on the same day each week (with or without meals). Most people start at a low dose and increase gradually to reduce GI side effects. Your clinician should show you the technique and how to use the pen safely on different injection sites.

Avoid changing other medicines (including OTC drugs and supplements) without checking with your clinician, because Ozempic® can interact with certain diabetes medications and may increase low blood sugar risk, especially when combined with insulin or sulfonylureas. Avoid dehydration, as nausea/vomiting can worsen kidney issues.

Ozempic® isn’t appropriate for everyone. It is generally contraindicated for people with a personal/family history of medullary thyroid carcinoma (MTC) or MEN 2. It should be used cautiously in people with certain conditions (like a history of pancreatitis or significant GI disease). Your clinician will screen you first. Inform your doctor if you have chronic kidney disease or gallbladder problems.

When Ozempic® is stopped, appetite regulation and blood sugar benefits may decrease, and some people regain weight if lifestyle support isn’t in place. That’s why many programs emphasize an ongoing plan with nutrition, movement, and follow-ups—so you can maintain progress whether you continue, switch, or discontinue medication.

Many patients notice reduced appetite, but early weeks often include GI side effects (like nausea or constipation), especially during dose increases. Clinicians typically start low and titrate up to improve tolerability, while monitoring for red flags and adjusting their treatment plan as needed.

Before starting, share your full medical history (especially thyroid cancer/MEN 2 history), current medications, and any history of pancreatitis or kidney problems. Review boxed warnings and learn which symptoms require urgent help (like severe abdominal pain or neck swelling). Your clinician will confirm eligibility and safety first.